May 14, 2018 / 2:03 PM / a year ago

U.S. considering expanding Medicare drug price negotiation

NEW YORK, May 14 (Reuters) - The U.S. is considering expanding Medicare’s ability to negotiate the cost of drugs, Health and Human Services Secretary Alex Azar said in prepared remarks on Monday that followed up on President Trump’s speech on drug pricing last week.

Azar said his agency will be considering an alternative system for buying Medicare Part B drugs, which would expand the negotiation of prescription drugs that are already covered under Medicare Part D.

Azar also said that President Trump has called for merging Medicare Part B into Part D. (Reporting by Michael Erman)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below